China Tops U.S. In Healthcare Expansion Destination But Regulatory Burdens Weigh – Survey
This article was originally published in PharmAsia News
Executive Summary
Despite a deepening economic slowdown and ongoing market access challenges, China overtook the U.S. as the top destination for expansion in a survey of global healthcare executives. Meanwhile, the 300-plus executives surveyed by UPS also rank regulatory hurdles above cost as the top barrier to expansion.